Yunxia Mm Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yunxia Mm Lin has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Lihua Jin
Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China
3 shared publications - Huiling Zheng
Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Xinhua Hospital of Zhejiang Province, Hangzhou, China
2 shared publications - Jiali Liu
State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China
2 shared publications - Jiali Mm Liu
Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China
2 shared publications - Ruilan Mm Li
Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Xinhua Hospital of Zhejiang Province, Hangzhou, China
2 shared publications - Yi Mm Yang
Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Xinhua Hospital of Zhejiang Province, Hangzhou, China
2 shared publications
Latest Publications
- Open Access
- 9 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (19) , e42327
Massive pulmonary embolism after cesarean section in a pregnant with occult pneumonia after COVID-19 infection: A case report
Rationale: Pregnant and postpartum women have a hypercoagulable state, and COVID-19 infection further heightens the risk of venous thromboembolism, with pulmonary embolism (PE) in COVID-19-infected pregnant women being a global concern. Patient concerns: A 47-year-old pregnant woman with a history of 3 vaginal deliveries and 1 cesarean section, who had a neo-coronavirus infection 29 days ago with rapid symptom resolution, developed asymptomatic massive PE within 24 hours after cesarean section at 38+ weeks of gestation. Diagnoses: Massive PE was diagnosed by computed tomography pulmonary angiography, which showed thromboembolism in multiple parts of the pulmonary arteries, along with pleural effusion and lung inflammation. Cardiac ultrasound revealed mildly elevated pulmonary artery systolic pressure and mild mitral and tricuspid regurgitation. Interventions: Anticoagulation therapy was initially with enoxaparin sodium injection, and the dosage was adjusted. Intravenous anti-infection therapy was also given. After discharge, the patient was switched to rivaroxaban. Compression stockings were used for venous thromboembolism prevention. Outcomes: After 5 months of anticoagulation therapy, the computed tomography pulmonary angiography of the pulmonary artery was completely normalized, but a small amount of interstitial lung lesions still persisted. Lessons: Pregnant women infected with the new coronavirus need close attention during pregnancy and puerperium, especially those with thrombosis risk factors who should receive early anticoagulation. There are many aspects worthy of further exploration, such as the necessity of early pulmonary computed tomography scans and appropriate anticoagulant dosage in pregnant women with COVID-19 infection.
- 9 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (19) , e42327
Open AccessMassive pulmonary embolism after cesarean section in a pregnant with occult pneumonia after COVID-19 infection: A case report
Rationale: Pregnant and postpartum women have a hypercoagulable state, and COVID-19 infection further heightens the risk of venous thromboembolism, with pulmonary embolism (PE) in COVID-19-infected pregnant women being a global concern. Patient concerns: A 47-year-old pregnant woman with a history of 3 vaginal deliveries and 1 cesarean section, who had a neo-coronavirus infection 29 days ago with rapid symptom resolution, developed asymptomatic massive PE within 24 hours after cesarean section at 38+ weeks of gestation. Diagnoses: Massive PE was diagnosed by computed tomography pulmonary angiography, which showed thromboembolism in multiple parts of the pulmonary arteries, along with pleural effusion and lung inflammation. Cardiac ultrasound revealed mildly elevated pulmonary artery systolic pressure and mild mitral and tricuspid regurgitation. Interventions: Anticoagulation therapy was initially with enoxaparin sodium injection, and the dosage was adjusted. Intravenous anti-infection therapy was also given. After discharge, the patient was switched to rivaroxaban. Compression stockings were used for venous thromboembolism prevention. Outcomes: After 5 months of anticoagulation therapy, the computed tomography pulmonary angiography of the pulmonary artery was completely normalized, but a small amount of interstitial lung lesions still persisted. Lessons: Pregnant women infected with the new coronavirus need close attention during pregnancy and puerperium, especially those with thrombosis risk factors who should receive early anticoagulation. There are many aspects worthy of further exploration, such as the necessity of early pulmonary computed tomography scans and appropriate anticoagulant dosage in pregnant women with COVID-19 infection.
- Open Access
- 8 December 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (49) , e36382
Sanji Peiyuan decoction combined with dydrogesterone in the treatment of massive subchorionic hematoma: A case report
Rationale: Subchorionic Hematoma, often referred to as Bruce hematoma, can lead to serious obstetric complications such as intrauterine growth restriction and fetal death, as well as early and late pregnancy miscarriage, placental abruption, and premature rupture of membranes, posing great harm to both mother and fetus. Patient concerns: At present, Western medical treatments have not shown satisfactory results, necessitating the discovery of more effective clinical treatment methods. Diagnoses: Threatened miscarriage, Subchorionic hematoma, Iron deficiency anemia (mild). Interventions: Sanji Peiyuan decoction combined with dydrogesterone. Outcomes: Following 17 days of treatment with Sanji Peiyuan decoction and oral dydrogesterone tablets, the hematoma was no longer detectable by ultrasound. The patient experienced no symptoms such as abdominal pain, bloating, or vaginal bleeding. She successfully gave birth around her due date, with both the mother and child in good health. Lessons: The combination of Sanji Peiyuan decoction and oral dydrogesterone tablets shows promising clinical efficacy in treating Massive Subchorionic Hematomas. This method merits further clinical research.
- 8 December 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (49) , e36382
Open AccessSanji Peiyuan decoction combined with dydrogesterone in the treatment of massive subchorionic hematoma: A case report
Rationale: Subchorionic Hematoma, often referred to as Bruce hematoma, can lead to serious obstetric complications such as intrauterine growth restriction and fetal death, as well as early and late pregnancy miscarriage, placental abruption, and premature rupture of membranes, posing great harm to both mother and fetus. Patient concerns: At present, Western medical treatments have not shown satisfactory results, necessitating the discovery of more effective clinical treatment methods. Diagnoses: Threatened miscarriage, Subchorionic hematoma, Iron deficiency anemia (mild). Interventions: Sanji Peiyuan decoction combined with dydrogesterone. Outcomes: Following 17 days of treatment with Sanji Peiyuan decoction and oral dydrogesterone tablets, the hematoma was no longer detectable by ultrasound. The patient experienced no symptoms such as abdominal pain, bloating, or vaginal bleeding. She successfully gave birth around her due date, with both the mother and child in good health. Lessons: The combination of Sanji Peiyuan decoction and oral dydrogesterone tablets shows promising clinical efficacy in treating Massive Subchorionic Hematomas. This method merits further clinical research.
- Open Access
- 25 August 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (34) , e34617
Clinical efficacy of Gualou Xiaoyong Decoction and painless lactation manipulation in treating lactation acute mastitis and breast abscess: An observational study
Information on the effects of Chinese medicine in the treatment of lactational acute mastitis and breast abscess is limited; thus, we conducted an observational study to analyze the clinical efficacy of Gualou Xiaoyong Decoction combined with painless lactation manipulation in the treatment of lactational acute mastitis and breast abscess. A total of 41 patients with lactational acute mastitis and breast abscess who were treated with Gualou Xiaoyong Decoction and painless lactation manipulation from October 2021 to October 2022 were included in this study. The age, fetal times(primiparous/multiparous), delivery mode (cesarean section/vaginal delivery), onset time, breast lump diameter, skin rash diameter, body temperature, visual analogue score, blood routine, C-reactive protein, procalcitonin, bacterial culture in milk, B ultrasound and other data of these patients were statistically analyzed. After treatment, the breast lump diameter of these patients decreased significantly, the skin rash diameter was reduced or disappeared, the body temperature decreased or returned to a normal range, and the visual analogue score also decreased. Besides, these patients had a decreased total number of white blood cells and a reduced percentage of neutrophils, C-reactive protein, and procalcitonin after treatment. In addition, bacteria in the milk of most patients disappeared, and there was no abnormality in B ultrasonic imaging. Except for 2 patients with breast abscess who stopped breastfeeding on the affected side for 1 day and 3 days respectively, all other patients continued to provide breast milk for their infants, and no adverse reactions were observed in these infants. The combination of Gualou Xiaoyong Decoction and painless lactation manipulation can achieve favorable clinical effects in the treatment of lactational acute mastitis and breast abscess. This combined therapy has good efficacy, short course of treatment, low costs, and great convenience with the avoidance of pain, hospitalization, influence on lactation, breast scar and other adverse outcomes.
- 25 August 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (34) , e34617
Open AccessClinical efficacy of Gualou Xiaoyong Decoction and painless lactation manipulation in treating lactation acute mastitis and breast abscess: An observational study
Information on the effects of Chinese medicine in the treatment of lactational acute mastitis and breast abscess is limited; thus, we conducted an observational study to analyze the clinical efficacy of Gualou Xiaoyong Decoction combined with painless lactation manipulation in the treatment of lactational acute mastitis and breast abscess. A total of 41 patients with lactational acute mastitis and breast abscess who were treated with Gualou Xiaoyong Decoction and painless lactation manipulation from October 2021 to October 2022 were included in this study. The age, fetal times(primiparous/multiparous), delivery mode (cesarean section/vaginal delivery), onset time, breast lump diameter, skin rash diameter, body temperature, visual analogue score, blood routine, C-reactive protein, procalcitonin, bacterial culture in milk, B ultrasound and other data of these patients were statistically analyzed. After treatment, the breast lump diameter of these patients decreased significantly, the skin rash diameter was reduced or disappeared, the body temperature decreased or returned to a normal range, and the visual analogue score also decreased. Besides, these patients had a decreased total number of white blood cells and a reduced percentage of neutrophils, C-reactive protein, and procalcitonin after treatment. In addition, bacteria in the milk of most patients disappeared, and there was no abnormality in B ultrasonic imaging. Except for 2 patients with breast abscess who stopped breastfeeding on the affected side for 1 day and 3 days respectively, all other patients continued to provide breast milk for their infants, and no adverse reactions were observed in these infants. The combination of Gualou Xiaoyong Decoction and painless lactation manipulation can achieve favorable clinical effects in the treatment of lactational acute mastitis and breast abscess. This combined therapy has good efficacy, short course of treatment, low costs, and great convenience with the avoidance of pain, hospitalization, influence on lactation, breast scar and other adverse outcomes.